Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88- dependent manner in dietary steatohepatitis

Liver International

Volumn 34, Issue 9, 2014, Pages 1402-1413

  Csak, Timea ^a   Pillai, Arun ^a   Ganz, Michal ^a   Lippai, Dora ^a   Petrasek, Jan ^a   Park, Jin Kyu ^a   Kodys, Karen ^a   Dolganiuc, Angela ^a   Kurt Jones, Evelyn A ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

AIM2; Caspase 1; HMGB1; IL 1 ; Inflammasome; MyD88; NLRP3; Nonalcoholic steatohepatitis; TLR4; TLR9

Indexed keywords

ABSENT IN MELANOMA 2 PROTEIN; CHOLINE; CRYOPYRIN; DNA; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; METHIONINE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; AIM2 PROTEIN, MOUSE; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; DNA BINDING PROTEIN; MYD88 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; KNOCKOUT MOUSE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; WILD TYPE; ANIMAL; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VITAMIN DEFICIENCY;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CARRIER PROTEINS; CHOLINE DEFICIENCY; DIET; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; INFLAMMASOMES; METHIONINE; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NON-ALCOHOLIC FATTY LIVER DISEASE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 84908238878     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12537     Document Type: Article

References (45)

1. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-71.
2. Rubartelli A, Lotze MT. Inside, outside, upside down:damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2010; 28: 429-36.
3. Miura K, Kodama Y, Inokuchi S, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1 beta in mice. Gastroenterology 2010; 139: e7.
4. Seki E, Brenner A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-35.
5. Muruve DA, Pétrilli V, Zaiss AK, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers innate immune response. Nature 2008; 452: 103-8.
6. Bauernfeind F, Ablasser A, Bartok E, et al. Inflammasomes:current understanding and open questions. Cell Mol Life Sci 2011; 68: 765-83.
7. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.
8. Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-91.
9. Kitazumi I, Tsukahara M. Regulation of DNA fragmentation:the role of caspases and phosphorylation. FEBS J 2011; 278: 427-41.
10. Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44: 27-33.
11. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-7.
12. Caro P, Gómez J, Arduini A, et al. Mitochondrial DNA sequences are present inside nuclear DNA in rat tissues and increase with age. Mitochondrion 2010; 10: 479-86.
13. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-50.
14. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-5.
15. Yan W, Chang Y, Liang X, et al. High mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 2012; 55:1863-75.
16. Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensing microbes. Dig Dis 2010; 28: 737-44.
17. Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2011; 300:G433-41.
18. Li L, Chen L, Hu L, et al. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 2011; 54:1620-30.
19. Hosoi T, Yokoyama S, Matsuo S, Akira S,Ozawa K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS ONE 2010; 5: e12537.
20. Csak T, Ganz M, Pespisa J, et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54: 133-44.
21. Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-85.
22. Witek RP, Stone WC, Karaca FG, et al. Pan-Caspase inhibitor VX-166 reduces firbosis in an animal model of nonalcoholic steatoehaptitis. Hepatology 2009; 50:1421-30.
23. Anstee QM, Concas D, Kudo H, et al. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J Hepatol 2010; 53:542-50.
24. Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE. Caspase-1-mediated regulation of fibrogenesis in dietinduced steatohepatitis. Lab Invest 2012; 92: 713-23.
25. Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 2011; 108: 15324-9.
26. Petrasek J, Bala S, Csak T, et al. Il-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012; 122: 3476-89.
27. Petrasek J, Dolganiuc A, Csak T, et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 2011; 53:649-60.
28. Kleiner DE, Brunt EM, Natta MV, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
29. Tang D, Kang R, Zeh HJ III, Lotze MT. High mobility group box 1, oxidative stress and disease. Antioxid Redox Signal 2011; 14: 1315-35.
30. Petrasek J, Dolganiuc A, Csak T, Kurt-Jones EA, Szabo G. Type I interferons protect from toll-like receptor 9- associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 2011; 140: 697-708.
31. Romics L Jr, Dolganiuc A, Velyudham A, et al. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes. J Leukoc Biol 2005; 78: 1255-64.
32. Hritz I, Velayudham A, Dolganiuc A, et al. Bone marrowderived immune cells mediate sensitization to liver injury in a Myeloid Differentiation Factor 88-dependent fashion. Hepatology 2008; 48: 1342-7.
33. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-46.
34. Szabo G, Velayudham A, Romics L Jr, Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 2005; 29: 140S-5S.
35. Burdette D, Haskett A, Presser L, et al. Hepatitis C virus activates interleukin-1{beta} via caspase-1-inflammasome complex. J Gen Virol 2012; 93: 235-46.
36. Szabo G, Csak T. Inflammasome in liver diseases. J Hepatol 2012; 57: 642-54.
37. Zaki MH, Boyd KL, Vogel P, et al. The NLRP3 inflammasome protects against loss of epithelial intergrity and mortality during experimental colitis. Immunity 2010; 32:379-91.
38. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006; 126: 1135-45.
39. Menzel CL, Sun Q, Loughran PA, et al. Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med 2011; 17: 1031-8.
40. Imaeda AB, Watanabe A, Sohail MA, et al. Acetaminophen- induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009; 119:305-14.
41. Yanai H, Ban T, Wang Z, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009; 462: 99-103.
42. Zhang X, Wheeler D, Tang Y, et al. Calcium/calmodulindependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages. J Immunol 2008; 181: 5015-23.
43. Ivanov S, Dragoi AM, Wang X, et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007; 110: 1970-81.
44. Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 2008; 23: 1635-48.
45. Al-Humaidi H, Zarros A, Kyriakaki A, Al-Saigh R, Liapi C. Choline deprivation: an overview of the major hepatic metabolic response pathways. Scand J Gastroenterol 2012; 47: 874-86